|
UBN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.910190E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036440E-02 |
| Normal-vs-Stage2 |
1.015830E-01 |
| Normal-vs-Stage3 |
1.598260E-02 |
| Normal-vs-Stage4 |
9.935800E-02 |
| Stage1-vs-Stage2 |
8.430200E-01 |
| Stage1-vs-Stage3 |
8.060400E-01 |
| Stage1-vs-Stage4 |
6.916800E-01 |
| Stage2-vs-Stage3 |
7.178800E-01 |
| Stage2-vs-Stage4 |
8.793600E-01 |
| Stage3-vs-Stage4 |
5.639000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.113700E-02 |
| Normal-vs-AfricanAmerican |
9.780800E-01 |
| Normal-vs-Asian |
1.102000E-01 |
| Caucasian-vs-AfricanAmerican |
1.844440E-01 |
| Caucasian-vs-Asian |
9.397000E-01 |
| AfricanAmerican-vs-Asian |
2.505800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.162200E-03 |
| Normal-vs-Female |
3.372500E-02 |
| Male-vs-Female |
4.091200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.937900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.185740E-02 |
| Normal-vs-Age(61-80Yrs) |
2.182200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.091800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.429600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.307000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.702200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.550800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.990400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.429800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.731800E-01 |
| Classical-VS-Follicular |
1.6374099999994E-05 |
| Classical-VS-Other |
6.424300E-02 |
| Classical-VS-Normal |
2.081800E-01 |
| Tall-VS-Follicular |
1.516000E-02 |
| Tall-VS-Other |
7.910400E-02 |
| Tall-VS-Normal |
2.815200E-01 |
| Follicular-VS-Other |
7.151800E-01 |
| Follicular-VS-Normal |
3.88009999999772E-05 |
| Other-VS-Normal |
1.364300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.143910E-02 |
| Normal-vs-N1 |
1.735760E-02 |
| N0-vs-N1 |
6.571000E-01 |
|
|
